The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122120075 12212007 5 F 2015 20160704 20160325 20160711 EXP PHHY2015BR118326 NOVARTIS 0.00 F Y 59.00000 KG 20160711 MD BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122120075 12212007 1 PS AFINITOR EVEROLIMUS 1 Oral 1 DF OF 5 MG, QD Y SA353/SC606 22334 5 MG TABLET QD
122120075 12212007 2 C AROMASIN EXEMESTANE 1 Oral 1 DF, QD 0 1 DF TABLET QD
122120075 12212007 3 C ZOMETA ZOLEDRONIC ACID 1 Oral 1 DF, Q3MO 0 1 DF AMPOULE
122120075 12212007 4 C VITAMIN D CHOLECALCIFEROL 1 Oral 8 DF, QD 0 8 DF DROPS QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122120075 12212007 1 Breast cancer metastatic
122120075 12212007 2 Breast cancer
122120075 12212007 3 Bone disorder
122120075 12212007 4 Bone disorder

Outcome of event

Event ID CASEID OUTC COD
122120075 12212007 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
122120075 12212007 Abdominal pain
122120075 12212007 Acne
122120075 12212007 Alopecia
122120075 12212007 Aphthous ulcer
122120075 12212007 Arthralgia
122120075 12212007 Blister
122120075 12212007 Blood cholesterol increased
122120075 12212007 Bone pain
122120075 12212007 Cough
122120075 12212007 Decreased immune responsiveness
122120075 12212007 Drug ineffective
122120075 12212007 Dysgeusia
122120075 12212007 Epistaxis
122120075 12212007 Influenza
122120075 12212007 Limb injury
122120075 12212007 Malaise
122120075 12212007 Mass
122120075 12212007 Nasal discomfort
122120075 12212007 Nasal disorder
122120075 12212007 Nasal injury
122120075 12212007 Oropharyngeal discomfort
122120075 12212007 Pain in extremity
122120075 12212007 Peripheral swelling
122120075 12212007 Pruritus
122120075 12212007 Pyrexia
122120075 12212007 Saliva altered
122120075 12212007 Skin atrophy
122120075 12212007 Skin exfoliation
122120075 12212007 Stomatitis
122120075 12212007 Weight decreased
122120075 12212007 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122120075 12212007 1 20150813 0
122120075 12212007 2 20150818 0
122120075 12212007 3 2015 0